| First Author | Duan XY | Year | 2014 |
| Journal | Cancer Lett | Volume | 345 |
| Issue | 2 | Pages | 230-4 |
| PubMed ID | 23941829 | Mgi Jnum | J:206989 |
| Mgi Id | MGI:5553438 | Doi | 10.1016/j.canlet.2013.07.033 |
| Citation | Duan XY, et al. (2014) NAFLD leads to liver cancer: Do we have sufficient evidence?. Cancer Lett 345(2):230-4 |
| abstractText | Primary liver cancer has several well-recognized risk factors, such as HBV and HCV infection, alcohol abuse and aflatoxin. Recent studies show that nonalcoholic fatty liver disease (NAFLD), especially its aggressive form nonalcoholic steatohepatitis (NASH) is associated with an increased risk of liver cancer, mainly hepatocellular carcinoma (HCC). On the other hand, clinical and epidemiological data have showed that HCC has rarely been found in a "pure" fatty liver in human. Thus, the question we need to ask is do we have sufficient evidence to support a causative role of NAFLD in liver cancer? Furthermore, if NAFLD is indeed a causative factor for liver cancer, what is the mechanism? Perhaps at this stage, fatty liver and NASH can be regarded as a definite risk factor for liver cancer, but to conclude that NAFLD induces HCC requires more robust in vitro and in vivo data. |
